Fundraising Fox

Eli Casdin

Investor

Chief Investment Officer and Founder at Casdin Capital

New York, New York

Writes $100K – $5M checks · typically $1.5M

About

Eli Casdin authored mid-2000s roadmap The Dawn of Molecular Medicine and backs platforms using biological data as decision-making infrastructure while guiding companies to markets via co‑sponsored CM Life Sciences SPACs.

Invests in

AgTechBiotechData & InfrastructureFoodTechHealthtechMedical Devices

Experience

  1. Casdin Capital, LLCChief Investment Officercurrent2011 — presentGreater New York City Area
  2. The Rockefeller UniversityBoard Membercurrent2021 — present
  3. New York Genome CenterBoard Membercurrent2020 — presentNew York, United States
  4. Columbia University School of General StudiesMember, Board of Visitorscurrent2015 — present
  5. Standard BioToolsBoard Membercurrent2022 — present
  6. GeneDxBoard Membercurrent2020 — present
  7. Prominex Inc.Board Membercurrent2018 — presentSan Diego, California
  8. GenomaticaBoard Membercurrent2018 — present
  9. SomaLogicBoard Member2020 — 2024
  10. Tenaya TherapeuticsBoard Member2019 — 2022
  11. EQRxBoard Member2020 — 2022
  12. Exact SciencesBoard Of Directors2017 — 2020Madison, Wisconsin
  13. Relay TherapeuticsBoard Observer2017 — 2019Cambridge, Massachusetts
  14. Magenta TherapeuticsBoard Observer2018 — 2019Cambridge, Massachusetts
  15. Fulcrum TherapeuticsBoard Observer2018 — 2019Cambridge, Ma
  16. InvitaeBoard Observer2013 — 2015
  17. SynapDxBoard Observer2013 — 2015
  18. Alliance BernsteinAnalyst2007 — 2011
  19. Bear StearnsAssociate2007
  20. Cooper Hill PartnersAnalyst2003 — 2006

Education

  1. Columbia Business SchoolMBA, Finance - Accounting2002 — 2003
  2. Columbia UniversityBachelor of Science2001 — 2003
  3. University of Vermont1991 — 1993
  4. Riverdale Country School1987 — 1991

Same school

Shared employers

Deals · 8

PAIGE.AI, Inc.Board seat

via Casdin Capital · filed Mar 2023 · $39M raise

Cedilla Therapeutics, Inc.Board seat

via Casdin Capital · filed Oct 2021 · $82.6M raise

GenomaticaBoard seat

via Casdin Capital · filed Aug 2021 · $119.1M raise

C2i Genomics, Inc.Board seat

via Casdin Capital · filed Apr 2021 · $100M raise

AbsciBoard seat

via Casdin Capital · filed Mar 2021 · $125M raise

Century Therapeutics, Inc.Board seat

via Casdin Capital · filed Mar 2021 · $160M raise

SOMALOGIC, INCBoard seat

via Casdin Capital · filed Jan 2021 · $250M raise

Vitruvian NetworksBoard seat

via Casdin Capital · filed Nov 2020 · $75M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Casdin Capital

Network6

Investors connected to Eli in public investor directories — a warm-intro map.